Verona Pharma (VRNA) shares continue to show some of the best relative strength in the pharma group and market overall as the stock has stayed above its YTD VWAP of 58 and seeing the 8/21 EMA in bull mode still. VRNA pulled back into the 8 EMA Thursday but a bounce from here can likely breakout to new highs over 70 and possibly further if markets get some stability into next week. VRNA still has the 400 near-the-money April $65 puts short puts in OI that sold to open at 5.10 on 2/21 as well as 500 January $65 calls bought at $11.90.